Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200057956Phase 4Completed
Phase 4, randomised trial in None comparing Dexmedetomidine + propofol with Sufentanil + propofol (2 arms). Primary endpoint: Unit propofol. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200057956.